期刊文献+

ERK/MAPK信号通路激活与乳腺癌细胞浸润性生长的关系 被引量:17

The relationship between the activation of ERK/MAPK signal transduction pathway and the invasive growth of breast cancer cells
暂未订购
导出
摘要 目的 :探讨乳腺癌细胞中ERK/MAPK信号转导通路异常激活与乳腺癌细胞浸润性生长的关系及可能机制。 方法 :采用Western蛋白印迹技术检测乳腺癌细胞系MCF 7和MDA MB 4 35S中磷酸化ERK/MAPK(p ERK)蛋白表达 ,以及表皮生长因子 (EGF)、胰岛素样生长因子 1(IGF 1)和ERK/MAPK通路抑制剂PD980 5 9对两种细胞ERK/MAPK信号转导通路磷酸化的调节。 结果 :雌激素受体ER(- )的浸润性乳腺癌细胞系MDA MB 4 35S中 ,p ERK表达明显高于ER(+)的非浸润性乳腺癌细胞系MCF 7;EGF可刺激两种细胞p ERK的表达增加 ,但这种刺激作用在MDA MB 4 35S细胞中更加明显 ;IGF 1则仅能刺激MCF 7细胞中p ERK的表达。PD980 5 9能有效阻滞EGF、IGF 1对p ERK的激活。 结论 :ERK/MAPK信号转导通路的异常激活与乳腺癌的浸润性生长有关 ,而EGF可能是异常激活ERK/MAPK信号转导通路 ,是刺激ER(- )的乳腺癌细胞浸润性生长的重要因素之一。 Objective:To address the relationship between ERK/MAPK phosphorylation (p-ERK) and the invasive growth of human breast cancer cells and its possible mechanism. Methods:The protein expressions of p-ERK in human breast cancer cell MCF-7 and MDA-MB- 435s were examined and the regulations of EGF, IGF-1 and ERK/MAP kinase specific inhibitor , PD98059 on these two kinds of cells. Results:Compared with ER-positive and no-invasive MCF-7 cells, the ER-negative and invasive MDA-MB- 435s cells had higher p-ERK protein expression. EGF stimulation induced more p-ERK activation in MDA-MB- 435s cells than that in MCF-7 cells. But IGF-1 only actived p-ERK signal transduction pathway in MCF-7 cells obviously. Treatment with PD98059 could block this activation in the two kinds of cells. Conclusion :The increasing of p-ERK activity was related to the malignant invasive growth of breast cancer cells and EGF was one of the important factors to activate ERK/MAPK signal transduction pathway to promote the cell invasive proliferation.
出处 《医学研究生学报》 CAS 2004年第6期490-492,共3页 Journal of Medical Postgraduates
关键词 乳腺癌 丝裂素活化蛋白激酶 信号转导 浸润性生长 Breast cancer Mitogen-activated protein kinase Signal transduction Invasive growth
  • 相关文献

参考文献10

  • 1[1]Pearson G, Robinson F, Beers GT et al. Mitogen-activated protein(MAP) kinase pathways: regulation and physiological functions[J].Endocr Rev, 2001,22(2): 153-183.
  • 2[2]Gee JM, Robertson JF, Ellis IO et al. Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer[J].Int J Cancer,2001,95(4):247-254.
  • 3[3]Santen RJ, Song RX, McPherson R et al.The role of mitogen-activated protein (MAP) kinase in breast cancer. J Steroid Biochem[J].Mol Biol,2002,80(2):239-256.
  • 4[4]Krueger JS, Keshamouni VG, Atanaskova N et al. Temporal and quantitative regu lation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion[J]. Oncogene, 2001,20(31):4209-4218.
  • 5[5]Coutts AS, Murphy LC.Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells [J].Cancer Res, 1998,58(18):4071-4074.
  • 6[6]Keshamouni VG, Mattingly RR, Reddy KB. Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells:a role for HER2 and PKC-delta[J].J Biol Chem,2002,277(25):22558-22565.
  • 7[7]Prifti S, Mall P, Strowitzki T et al.Synthetic estrogens-mediated activation of JNK intracellular signaling molecule[J].Gynecol Endocrinol, 2001,15(2):135-141.
  • 8[8]Rincon SV, Rousseau C, Samanta R et al. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway [J].Oncogene, 2003,22(22):3353-3360.
  • 9[9]Bartucci M, Morelli C, Mauro L et al. Differential insulin-like growth factor receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells[J]. Cancer Res,2001,61(18):6747-6754.
  • 10[10]cClelland RA, Barrow D, Madden TA et al. Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex) [J].Endocrinology, 2001,142(7) :2776-2788.

同被引文献211

引证文献17

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部